JPH0242009A - External preparation - Google Patents

External preparation

Info

Publication number
JPH0242009A
JPH0242009A JP19297188A JP19297188A JPH0242009A JP H0242009 A JPH0242009 A JP H0242009A JP 19297188 A JP19297188 A JP 19297188A JP 19297188 A JP19297188 A JP 19297188A JP H0242009 A JPH0242009 A JP H0242009A
Authority
JP
Japan
Prior art keywords
rottlerin
external preparation
phase part
lotion
kamala
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP19297188A
Other languages
Japanese (ja)
Other versions
JP2610310B2 (en
Inventor
Yasuaki Oyama
康明 大山
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sansho Pharmaceutical Co Ltd
Original Assignee
Sansho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sansho Pharmaceutical Co Ltd filed Critical Sansho Pharmaceutical Co Ltd
Priority to JP19297188A priority Critical patent/JP2610310B2/en
Publication of JPH0242009A publication Critical patent/JPH0242009A/en
Application granted granted Critical
Publication of JP2610310B2 publication Critical patent/JP2610310B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)

Abstract

PURPOSE:To obtain an external preparation preventing stain, freckle, etc., exhibiting excellent fair-complexioned effects comprising rottlerin, a component of kamala of gland seta and bundle fiber, occurring in epidermis of fruit of Mallotus philoppinwnaia Muller Argoviensis as an active ingredient. CONSTITUTION:A cosmetic such as cream, toilet lotion or pack and a quasi-drug such as emulsion, lotion or liniment containing 1-0.01wt.% rottlerin shown by the formula obtained by extraction and purification from kamala. Cream, ointment, milky lotion, etc., are prepared by adding rottlerin to an oil phase part and blending the oil phase part with a water phase part. The external preparation is safely usable without causing disorder such as rash of skin.

Description

【発明の詳細な説明】 〔産業上の利用分野〕 本発明はカマラの成分であるロットレリンを有効成分と
した、シミ、ソバカスなどのメラニン生成による皮膚の
諸現象を防止すると共に、色白効果の優れた外用剤に関
するものである。
[Detailed Description of the Invention] [Field of Industrial Application] The present invention uses rottlerin, a component of Kamala, as an active ingredient to prevent various skin phenomena caused by melanin production such as spots and freckles, and has an excellent skin whitening effect. This topic relates to external preparations.

〔従来の技術〕[Conventional technology]

従来、メラニン生成を抑制する物質としては、コウジ酸
、コウジ酸誘導体が知られてる。そして、それらの物質
を有効成分とした色白化粧料も、例えば特公昭56−1
8569号、特開昭56−7710 号、同56−77
76号、同56−79616号公報等に種々開示されて
いる。また、フラボノール系化合物も知られている。例
えば、クエルセチンを有効成分とした化粧料、皮膚塗布
剤としては、特開昭55−92305号、同57−14
517号公報に開示され、クエルセチン脂肪酸エステル
を有効成分としたものとしては、特公昭58−3447
7号公報に開示され、ミリセチン、フィセチン、グチス
セチン、ラムネチンなどを有効成分としたものとしては
、特開昭55−111411 号、同57−35506
号公報に開示されている。また、3−ヒドロキシクロモ
ン系化合物を有効成分としたものとしては、特開昭55
−111410 号、同55−143908 号公報に
それぞれ開示されている。
Conventionally, kojic acid and kojic acid derivatives are known as substances that suppress melanin production. Furthermore, skin fairing cosmetics containing these substances as active ingredients were also produced, for example, in
No. 8569, JP-A-56-7710, JP-A No. 56-77
Various disclosures are made in No. 76, No. 56-79616, and the like. Flavonol compounds are also known. For example, cosmetics and skin liniments containing quercetin as an active ingredient include JP-A-55-92305 and JP-A-57-14.
As disclosed in Japanese Patent Publication No. 517 and containing quercetin fatty acid ester as an active ingredient, Japanese Patent Publication No. 58-3447
7, which contains myricetin, fisetin, gutiscetin, rhamnetin, etc. as active ingredients, include JP-A-55-111411 and JP-A-57-35506.
It is disclosed in the publication No. In addition, as an active ingredient of 3-hydroxychromone compound, there is
-111410 and No. 55-143908, respectively.

〔発明が解決しようとする課題〕[Problem to be solved by the invention]

本発明は安全かつ有効なメラニン生成抑制効果を有する
新たな外用剤を提供することを目的とするものである。
The object of the present invention is to provide a new external preparation that has a safe and effective melanin production inhibiting effect.

〔課題を解決するための手段〕[Means to solve the problem]

本発明者は、新たなメラニン生成抑制物質を広く検索、
研究を重ねたところ、本発明者が先にメラニン生成抑制
物質として見出したカマラチンキ(特開昭63−291
3 号公報参照)の成分であるロットレリンが優れたメ
ラニン生成抑制作用を有することを見出し本発明を完成
した。
The present inventor conducted a wide search for new melanin production inhibitors,
After repeated research, the present inventor discovered Kamala tincture (Japanese Patent Application Laid-Open No. 63-291
The present invention was completed based on the discovery that rottlerin, a component of the product (see Publication No. 3), has an excellent melanin production inhibiting effect.

本発明はロットレリンを有効成分とする外用剤である。The present invention is an external preparation containing rottlerin as an active ingredient.

本発明のロットレリンは下記構造式を有する化合物であ
る。
Rottlerin of the present invention is a compound having the following structural formula.

この化合物はクスノキガシワの果実の表皮に生じた腺毛
及び束毛であるカマラを原料として抽出精製した公知の
物質である。
This compound is a known substance extracted and purified from Kamala, which is the glandular hairs and bundles of hairs produced on the epidermis of the camphor tree fruit.

原料のカマラは虫体の運動神経及び筋を麻痺させること
により駆虫効果を現し、また瀉下作用を有することが知
られている。
Kamala, the raw material, is known to have an anthelmintic effect by paralyzing the motor nerves and muscles of the insect body, and also to have a cathartic effect.

本発明の外用剤はクリーム、化粧水、パック等の化粧料
の他、乳剤、ローション剤、リニメント剤等の外用に用
いられる医薬部外品を含む意味に用いられる。
The external preparations of the present invention include cosmetics such as creams, lotions, and packs, as well as quasi-drugs used for external use such as emulsions, lotions, and liniments.

本発明の外用剤は、有効成分であるロットレリンを、化
粧料の場合は5〜0.001%(重量)、好ましくは1
〜0.01%(重量)、医薬部外品の場合は、10〜0
.001%(重量)、好ましくは1〜0.01%(重M
)含有する。
The external preparation of the present invention contains rottlerin as an active ingredient, in the case of cosmetics, 5 to 0.001% (by weight), preferably 1% (by weight).
~0.01% (weight), 10-0 for quasi-drugs
.. 001% (by weight), preferably 1-0.01% (by weight)
)contains.

外用剤に製剤化する場合、クリーム又は軟膏においては
、精製水に親水性成分例えば、グリセリン、ソルビット
などの保湿剤を添加して水相部とし、油相部はミツロウ
、パラフィン、マイクロクリスタリンワックス、セレシ
ン、高級脂肪酸、硬化油などの固形油分、ワセリン、ラ
ノリン、グリセリドなどの半固形油分、それにククワラ
ン、流動パラフィン、各種エステル油などの液状油分に
防腐剤、界面活性剤などの油成分を添加して調製する。
When formulating into external preparations, creams or ointments, hydrophilic ingredients such as humectants such as glycerin and sorbitol are added to purified water to form the aqueous phase, and the oil phase consists of beeswax, paraffin, microcrystalline wax, etc. Oil components such as preservatives and surfactants are added to solid oils such as ceresin, higher fatty acids, and hydrogenated oils, semi-solid oils such as vaseline, lanolin, and glycerides, and liquid oils such as cuqualane, liquid paraffin, and various ester oils. Prepare.

このようにして得られた水相部を加温して、緩やかに攪
拌しつつ同温度に加温された油相部を徐々に添加し乳化
してクリーム又は軟膏とする一般のクリーム又は軟膏の
製造において、油相部に有効成分であるロットレリンを
加えてクリーム又は軟膏とする。
A general cream or ointment is prepared by heating the aqueous phase obtained in this way and gradually adding the oil phase heated to the same temperature while stirring gently to emulsify it. During production, the active ingredient rottlerin is added to the oil phase to form a cream or ointment.

乳剤においては、精製水にグリセリンなどの保湿剤、酸
又はアルカリのpH調整剤などを加え、加温混合してエ
タノールを加え水相部とし、ミツロウ パラフィンなど
の固形油分、ワセリン、ラノリンなどの半固形油分、ス
クワラン、流動パラフィン、各種エステル油などの液状
油分に、防腐剤、界面活性剤などの油性成分を添加して
混合加熱し油相部とし、油相部を水相部に加えて予備乳
化を行い、これにカルボキシビニルポリマー、カルボキ
シメチルセルロースなどの保護コロイド剤を加え、ホモ
ミキサーで均一に乳化して乳剤とする一般の乳剤の製造
において、油相部に有効成分であるロットレリンを加え
て乳剤とする。
In the case of emulsions, humectants such as glycerin, acidic or alkaline pH adjusters, etc. are added to purified water, heated and mixed, ethanol is added to form the aqueous phase, and solid oils such as beeswax and paraffin, semi-containing substances such as vaseline and lanolin are added. Oily components such as preservatives and surfactants are added to liquid oils such as solid oils, squalane, liquid paraffin, and various ester oils, mixed and heated to form an oil phase, and the oil phase is added to the aqueous phase to form a reserve. In the production of general emulsions, in which emulsification is performed, a protective colloid such as carboxyvinyl polymer or carboxymethyl cellulose is added to the emulsion, and the emulsion is homogeneously emulsified using a homomixer, rottlerin, an active ingredient, is added to the oil phase. Make it into an emulsion.

パンク剤においては、精製水にグリセリンなどの保湿剤
、ポリビニルアルコール、ビーガムなどの皮膜剤などを
加えて膨潤させ、これに必要があればカオリン、タルク
、酸化亜鉛などの粉末を加え、香料、防腐剤などを溶解
したエタノールを加えてペースト状となるまで混練する
一般のパック剤の製造において、有効成分であるロット
レリンを加えてパック剤とする。
For puncture agents, moisturizers such as glycerin, film agents such as polyvinyl alcohol, and vegum are added to purified water to swell it, and if necessary, powders such as kaolin, talc, and zinc oxide are added to add fragrance and preservatives. In the production of general packs, which involve adding ethanol in which ingredients have been dissolved and kneading the mixture until it becomes a paste, rottlerin, an active ingredient, is added to form a pack.

次に本発明の実施例を挙げる。Next, examples of the present invention will be described.

〔実施例〕〔Example〕

例1 クリーム ロフトレリン         0.1%ポリオキシエ
チレンステアリルエーテル2.0% ポリオキシエチレンセチルエーテル 2.0% ミツロウ            6.0にセタノール
          6.0%イソプロビルパルミテー
)   10.0%流動パラフィン       30
.0%ポリエチレングリコールモノステアレート1.0
% バラオキシ安息酸メチル    0.2%精製水で全量
を100 とする。
Example 1 Cream loftrelin 0.1% polyoxyethylene stearyl ether 2.0% polyoxyethylene cetyl ether 2.0% beeswax 6.0% cetanol 6.0% isoprobyl palmitate) 10.0% liquid paraffin 30
.. 0% polyethylene glycol monostearate 1.0
% Methyl roseoxybenzoate 0.2% Make the total volume to 100 with purified water.

例2 乳剤 ロットレリン         0.01%自己乳化型
グリセロールモノステアレート0.5% ポリオキシエチレンセヂルエーテル 2.0% MCステアリン酸       2.0%セタノール 
         1.5%イソプロピルミリステー)
   10.0%バラオキシ安息呑酸メチル   0.
2%香料             微量 精製水で全量を100 とする。
Example 2 Emulsion Rottlerin 0.01% Self-emulsifying glycerol monostearate 0.5% Polyoxyethylene cedyl ether 2.0% MC stearic acid 2.0% Cetanol
1.5% isopropyl myristate)
10.0% Methyl roseoxybenzoate 0.
2% fragrance Make the total volume to 100% with a small amount of purified water.

例3 バック剤 ロットレリン          1.0%パラオキシ
安安息醋酸メチル  0.08%カルボキシビニルポリ
マー   1.0%炭酸カルシウム        0
.6%二酸化チタン         0.02%香料
              微量精製水で全量を10
(l とする。
Example 3 Backing agent Rottlerin 1.0% Methyl paraoxybenzoate 0.08% Carboxyvinyl polymer 1.0% Calcium carbonate 0
.. 6% titanium dioxide 0.02% fragrance A small amount of purified water makes the total amount 10%
(Let it be l.

なお、本実施例の%は重量%である。Note that % in this example is % by weight.

本発明の有効成分であるロソトレリンのメラニン生成抑
制作用について下記の試験により明らかにする。
The melanin production inhibiting effect of losotorelin, the active ingredient of the present invention, will be clarified by the following test.

試験例 Bi6細胞のメラニン生成試験 マウスメラノーマ由来B16細胞4X10’ 個を10
%牛脂児血清10m1を含んだイーグルMε;4培地に
懸濁し、25cm”培養用ルー瓶にて5%C02存在下
37℃で培養する。0日目及び3日目にロソトレリンを
それぞれ0,25μ!J/ 1 jI!、0.50 μ
M/1β、1.0μ:A/1β含む培地で交換し、5日
間培養する。細胞を0、8W/V食塩を含有するリン酸
緩衝液(pH7,2)で洗浄し、後トリプシン及びBD
TA含有溶液を使用して剥離し、濾過により細胞を回収
した。濾紙上に回収された細胞はデンシトメーターによ
り500nm における反射光度(黒色度)を求めた。
Test Example Melanin production test of Bi6 cells 4 x 10' mouse melanoma-derived B16 cells were
Suspended in Eagle Mε;4 medium containing 10 ml of % tallow serum and cultured at 37°C in the presence of 5% CO2 in a 25 cm” culture bottle. !J/ 1 jI!, 0.50 μ
M/1β, 1.0 μ: Replace with medium containing A/1β and culture for 5 days. Cells were washed with phosphate buffer (pH 7.2) containing 0.8 W/V saline, then trypsinized and BD
Cells were harvested by detachment using a TA-containing solution and filtration. The reflected light intensity (blackness) at 500 nm of the cells collected on the filter paper was determined using a densitometer.

試験結果は下記表1の通りであった。The test results were as shown in Table 1 below.

表  1 :変化なし +:やや薄い ++:明瞭に薄い +十十
:非常に薄い 以上の結果ロットレリン添加濃度に依存し、細胞の白色
化が認められた。
Table 1: No change +: Slightly thin ++: Clearly thin +10: Very thin As a result, whitening of cells was observed depending on the concentration of rottlerin added.

〔発明の効果〕〔Effect of the invention〕

本発明の外用剤は肌あれ、皮膚のカブレなどの障害を起
こすことなく安全に使用でき、皮膚の色白効果、シミ、
ソバカス等を防止する効果を有する極めて有用な発明で
ある。
The topical preparation of the present invention can be safely used without causing any problems such as rough skin or skin rash, and has a whitening effect on the skin, preventing spots and
This is an extremely useful invention that has the effect of preventing freckles and the like.

Claims (1)

【特許請求の範囲】[Claims] 1、ロットレリンを有効成分とすることを特徴とする外
用剤。
1. An external preparation characterized by containing rottlerin as an active ingredient.
JP19297188A 1988-08-01 1988-08-01 External preparation Expired - Lifetime JP2610310B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP19297188A JP2610310B2 (en) 1988-08-01 1988-08-01 External preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP19297188A JP2610310B2 (en) 1988-08-01 1988-08-01 External preparation

Publications (2)

Publication Number Publication Date
JPH0242009A true JPH0242009A (en) 1990-02-13
JP2610310B2 JP2610310B2 (en) 1997-05-14

Family

ID=16300091

Family Applications (1)

Application Number Title Priority Date Filing Date
JP19297188A Expired - Lifetime JP2610310B2 (en) 1988-08-01 1988-08-01 External preparation

Country Status (1)

Country Link
JP (1) JP2610310B2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102988190A (en) * 2012-12-28 2013-03-27 广州市白云区新东方日用化工品厂 Whitening combination and application thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102988190A (en) * 2012-12-28 2013-03-27 广州市白云区新东方日用化工品厂 Whitening combination and application thereof

Also Published As

Publication number Publication date
JP2610310B2 (en) 1997-05-14

Similar Documents

Publication Publication Date Title
JPS6324967B2 (en)
US5560904A (en) Cosmetic and/or dermatological composition containing a glyceryl tri(.alpha.
JPH03106810A (en) Whitening agent
JPH11263720A (en) Antiaging agent
KR100280898B1 (en) Novel salicylic acid derivatives and their use in a cosmetic and/or dermatological composition
JPH0859450A (en) External preparation for skin
JP3513872B2 (en) External preparation for skin
JPS625909A (en) Preventing agent for skin elastosis
JPH0532556A (en) Skin agent for external use
JPH06271452A (en) Skin cosmetic containing extract of plant of cactuses
JPH11171723A (en) Antioxidant
JP2001122733A (en) Catalase production-promoting preparation and skin preparation for external use containing the same
JP2000247987A (en) Highly hydrogenated lecithin
JP2501593B2 (en) Topical agent for suppressing melanin production
JP2656463B2 (en) Cosmetic or dermatological composition containing encapsulated plant extract
JP3140876B2 (en) Melanin production inhibitor and external preparation for skin
JP2004307469A (en) Use of n-arylmethylene ethylenediamine triacetate, n-arylmethylene iminodiacetate or n,n'-diarylmethylene ethylenediamine acetate as no donor
JPH0687730A (en) Cosmetic
JPH0242009A (en) External preparation
JP3441387B2 (en) Moisturizer, skin cosmetics and bath additives
JPH11501663A (en) Use of a carboxylic acid having a sulfur functional group for promoting exfoliation or stimulating epidermal regeneration
JP3912722B2 (en) Topical skin preparation
JPS62178506A (en) Melanin formation suppressing external preparation
JPH10203921A (en) Skin preparation for external use
JPH04334310A (en) Agent for suppressing formation of lipid peroxide

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090213

Year of fee payment: 12

EXPY Cancellation because of completion of term
FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090213

Year of fee payment: 12